Original Posted By hahaiyaa.20►
haiyaaa ciilaaka luuwa weelas waaa
Bukan nyeee negara Barat gak bise,tetapi apakah sang pasien mampu bayar!!??
New gene therapy treatment could hit $1M per patient because of additional costs
Negara2 Barat macam US etc segala hal hrs melalui procedure yg ber-belit2 macam risk,ethical evaluation,side effects etc waaa!!!
Blom lagi hrs melalui insurance agar ongkos jd murah,jd Treatmen nyee magh udeh ada!!!
Sedang kan China terkenal dgn hukum dan data abal2
jadi bagi J&J invest $350 juta nothing buat experiments,boleh dibilang mungkin gak ade resiko klo kelinci percobaan nyeee SICKmen of Asia mokat ato kena side effects waaa!!!
Bahkan PKC juga senang itung2 kurangin Sub-human oowtak 10CC yg hrs dikasih makan waaa!!!
Bayangkan klo terjadi di Amerika dituntut bisa bayar BILLIONS mighty U$ dollar,bukan luuwit ecek2 RMB waaa!!!
Multi-Billion Dollar Actos Settlement
In October 2015, Takeda Pharmaceuticals agreed to settle thousands of Actos bladder cancer lawsuits for $2.4 billion, and it is one of the largest settlements in drug and device history. In 2014, Takeda was hit with a massive $9 billion jury verdict in favor of one plaintiff who was diagnosed with bladder cancer after taking Actos.
Andaikate Land of SICK and RETARD begitu hebat nyeee ngapain Sampah SICKmen of Asia bayar puluhan ribu mighty U$ dollar masuk Kontainer bahkan banyak yg rela bayar jutaan mighty U$ dollar agar bise dpt Visa PR negara2 Barat!!!
Malah sampe ade yg rela bayar ratusan ribu mighty U$ dollar buat nikah boong2an agar bisa dpt PR!!!!
Ngapain Sickmen of Asia ber-bondong2 bayar ratusan ribu mighty U$ dollars berobat to the BEST country on earth!!!
Luuw pikir mereka bego haaa???
Hanya krn 1 Bule yg sangat kepepet ampe ini bisa hidup bukan berarti udeh benar2 sukses,emang luuw tau klo besok2 diyeee mati krn Side Effects pengobatan yg masih dlm tahap evaluasi!!!
BEIJING — China’s medical system could not stop the cancer eating at Guo Shushi’s stomach.
It roared back even after Mr. Guo, a 63-year-old real estate developer, endured surgery, chemotherapy and radiation at two hospitals.
Then his son-in-law discovered online that — for a price — companies were willing to help critically ill Chinese people seek treatment abroad.
Soon Mr. Guo was at the Dana-Farber Cancer Institute in Boston
, receiving a new immunotherapy drug, Keytruda, which is not available in China. In April, nearly four months later, his tumor has shrunk and his weight has gone up.
“When I arrived, I could feel how large the gap was,” said Mr. Guo of the difference in care.
The cost: about $220,000 — all paid out of pocket.
Chinese people took an estimated 500,000 outbound medical trips last year, a five fold increase from a year earlier,
according to Ctrip.com International, a Chinese travel booking company, which offers medical travel on its website. While the bulk of that is focused on plastic surgery and routine examinations, medical travel agencies say the number of critically ill Chinese patients leaving the country for medical treatment is growing.
“China is among the countries where we have seen the greatest growth in recent years,” Dr. Stephanie L. Hines, the chairwoman of executive health and international medicine at the Mayo Clinic, said in an email.